Wayne, an advocate of the BioInnovate process, utilised the skillsets of his peers Liam Mullins and Colin Forde to become BioInnovate’s first spinout company CEO with Embo Medical. Between mid-2012 and August 2016, both he, Colin and Liam worked diligently to create a novel solution for one shot reliable embolistaion and achieved almost €3.5million in funding during a 2 year period from Enterprise Ireland and AIB’s Seed Capital Fund. Subsequently in 2016, Embo Medical was acquired by CR Bard’s subsidiary Clearstream for almost €43.5 million. Following the acquisition completion, Wayne now acts as CEO for a new startup NeuVT, working with Liam Mullins.